Biomarker Commercialization

Pathway Diagnostics is a leader in development and commercialization of the biomarker assays that are accelerating personalized medicine and pharmacogenetics. The unique combination of our insight into developing companion diagnostic needs, access to sample cohorts and expertise in diagnostic assay development is leveraged to transform the potential of an early stage biomarker into a clinically-validated diagnostic. We are working in a wide variety of therapeutic areas including cardiovascular diseases, oncology, inflammatory and autoimmune diseases, infectious diseases and psychiatric disorders. We invite you to contact us to find out how Pathway Diagnostics can work with you to co-develop diagnostic biomarkers.